Neuropace (NPCE) Earnings Date & Reports

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NPCE is expected to report earnings to rise 8.62% to -22 cents per share on August 07

Q2'25

Est.

$-0.23

Q1'25

Beat

by $0.03

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.04

The last earnings report on May 13 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 225.22K shares outstanding, the current market capitalization sits at 385.20M.

View a ticker or compare two or three

Compare

NPCE